AR124044A1 - Cápsulas blandas de liberación retardada - Google Patents
Cápsulas blandas de liberación retardadaInfo
- Publication number
- AR124044A1 AR124044A1 ARP210103126A ARP210103126A AR124044A1 AR 124044 A1 AR124044 A1 AR 124044A1 AR P210103126 A ARP210103126 A AR P210103126A AR P210103126 A ARP210103126 A AR P210103126A AR 124044 A1 AR124044 A1 AR 124044A1
- Authority
- AR
- Argentina
- Prior art keywords
- coating composition
- dependent
- glycerin
- sorbitol
- delayed
- Prior art date
Links
- 230000003111 delayed effect Effects 0.000 title abstract 9
- 239000000499 gel Substances 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 16
- 230000001419 dependent effect Effects 0.000 abstract 16
- 239000008199 coating composition Substances 0.000 abstract 11
- 235000011187 glycerol Nutrition 0.000 abstract 8
- 239000000463 material Substances 0.000 abstract 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 7
- 239000000600 sorbitol Substances 0.000 abstract 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 5
- 239000013543 active substance Substances 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000001814 pectin Substances 0.000 abstract 3
- 235000010987 pectin Nutrition 0.000 abstract 3
- 229920001277 pectin Polymers 0.000 abstract 3
- 108010010803 Gelatin Proteins 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 239000008121 dextrose Substances 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 2
- 239000000945 filler Substances 0.000 abstract 2
- 239000008273 gelatin Substances 0.000 abstract 2
- 229920000159 gelatin Polymers 0.000 abstract 2
- 235000019322 gelatine Nutrition 0.000 abstract 2
- 235000011852 gelatine desserts Nutrition 0.000 abstract 2
- 239000007901 soft capsule Substances 0.000 abstract 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 abstract 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 229920002148 Gellan gum Polymers 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000000216 gellan gum Substances 0.000 abstract 1
- 235000010492 gellan gum Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002028 premature Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063112456P | 2020-11-11 | 2020-11-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR124044A1 true AR124044A1 (es) | 2023-02-08 |
Family
ID=81601781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210103126A AR124044A1 (es) | 2020-11-11 | 2021-11-11 | Cápsulas blandas de liberación retardada |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230404927A1 (enExample) |
| EP (1) | EP4243786A4 (enExample) |
| JP (1) | JP2023549177A (enExample) |
| KR (1) | KR20230106641A (enExample) |
| CN (1) | CN116685311A (enExample) |
| AR (1) | AR124044A1 (enExample) |
| AU (1) | AU2021377907A1 (enExample) |
| CA (1) | CA3197516A1 (enExample) |
| CO (1) | CO2023007156A2 (enExample) |
| IL (1) | IL302751A (enExample) |
| MX (1) | MX2023005450A (enExample) |
| TW (1) | TW202233165A (enExample) |
| WO (1) | WO2022104338A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102022104553A1 (de) * | 2022-02-25 | 2023-08-31 | Gelita Ag | Magensaftresistente Kapsel und deren Verwendung |
| KR102785453B1 (ko) * | 2022-06-21 | 2025-03-26 | 우리바이오(주) | 장용성 연질 캡슐용 겔 매스 조성물 |
| CA3264775A1 (en) * | 2022-08-12 | 2024-02-15 | R.P. Scherer Technologies, Llc | COATED ENTERIC SOFT-COATED CAPSULES |
| CN120282775A (zh) * | 2022-12-14 | 2025-07-08 | R·P·谢勒技术有限公司 | 软凝胶胶囊和制备软凝胶胶囊的方法 |
| WO2025009342A1 (ja) * | 2023-07-03 | 2025-01-09 | 三生医薬株式会社 | カプセル皮膜製造用組成物、カプセル皮膜製造用材料の製造方法及びカプセル皮膜 |
| CN120436302A (zh) * | 2024-02-08 | 2025-08-08 | 仙乐健康科技(广东)有限公司 | 一种果胶凝胶及其制备方法 |
| WO2025234509A1 (ko) * | 2024-05-08 | 2025-11-13 | 코스맥스바이오 주식회사 | pH 의존성 필름 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0427352A (ja) * | 1990-05-22 | 1992-01-30 | Fuji Capsule Kk | 健康食品用腸溶性軟カプセル |
| US5342626A (en) * | 1993-04-27 | 1994-08-30 | Merck & Co., Inc. | Composition and process for gelatin-free soft capsules |
| US6340473B1 (en) * | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| US20120301546A1 (en) * | 2011-05-26 | 2012-11-29 | Hassan Emadeldin M | Acid-resistant soft gel compositions |
| EP2793867B1 (en) * | 2011-12-22 | 2021-01-20 | Baes, Erik | Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof |
| US20130280323A1 (en) * | 2012-04-13 | 2013-10-24 | Banner Pharmacaps, Inc. | Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture |
| US20150366814A1 (en) | 2014-06-23 | 2015-12-24 | Banner Life Sciences Llc | All-natural enteric soft capsules comprising active ingredients |
| CN106456558B (zh) * | 2014-10-06 | 2019-10-08 | 富士胶囊股份有限公司 | 肠溶软胶囊的制备方法 |
| US10711119B2 (en) * | 2018-01-10 | 2020-07-14 | Cp Kelco Aps | Carrageenan-based compositions for films and capsules |
| WO2019178444A1 (en) * | 2018-03-15 | 2019-09-19 | R.P. Scherer Technologies, Llc | Enteric softgel capsules |
-
2021
- 2021-11-10 KR KR1020237018746A patent/KR20230106641A/ko active Pending
- 2021-11-10 EP EP21893067.5A patent/EP4243786A4/en active Pending
- 2021-11-10 IL IL302751A patent/IL302751A/en unknown
- 2021-11-10 MX MX2023005450A patent/MX2023005450A/es unknown
- 2021-11-10 AU AU2021377907A patent/AU2021377907A1/en active Pending
- 2021-11-10 CA CA3197516A patent/CA3197516A1/en active Pending
- 2021-11-10 JP JP2023528013A patent/JP2023549177A/ja active Pending
- 2021-11-10 CN CN202180089195.XA patent/CN116685311A/zh active Pending
- 2021-11-10 US US18/036,207 patent/US20230404927A1/en active Pending
- 2021-11-10 WO PCT/US2021/072325 patent/WO2022104338A1/en not_active Ceased
- 2021-11-11 AR ARP210103126A patent/AR124044A1/es unknown
- 2021-11-11 TW TW110142058A patent/TW202233165A/zh unknown
-
2023
- 2023-05-30 CO CONC2023/0007156A patent/CO2023007156A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2023005450A (es) | 2023-05-23 |
| WO2022104338A1 (en) | 2022-05-19 |
| EP4243786A4 (en) | 2024-10-23 |
| EP4243786A1 (en) | 2023-09-20 |
| CN116685311A (zh) | 2023-09-01 |
| CO2023007156A2 (es) | 2023-06-20 |
| KR20230106641A (ko) | 2023-07-13 |
| TW202233165A (zh) | 2022-09-01 |
| US20230404927A1 (en) | 2023-12-21 |
| CA3197516A1 (en) | 2022-05-19 |
| AU2021377907A1 (en) | 2023-06-15 |
| JP2023549177A (ja) | 2023-11-22 |
| IL302751A (en) | 2023-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR124044A1 (es) | Cápsulas blandas de liberación retardada | |
| AR124043A1 (es) | Cápsulas blandas de liberación retardada | |
| MX2022013695A (es) | Composicion encapsulada de microcapsulas de nucleo-cubierta y proceso para su preparacion. | |
| PE20061136A1 (es) | Sistema de capsulas blandas que no son de gelatina | |
| MX2022006907A (es) | Composiciones orales que incluyen geles. | |
| AR119075A1 (es) | Cápsulas blandas de liberación diferida | |
| AR100519A1 (es) | Envase tipo cápsula de gelatina blanda y su método de fabricación | |
| AR115269A1 (es) | Cápsulas de gelatina blanda entéricas | |
| DOP2012000217A (es) | Pastillas de gelatina blanda con nicotina | |
| CO2022007168A2 (es) | Cápsulas de gelatina blanda de liberación retardada en ambientes de ph más alto | |
| DK1898889T3 (da) | Brudbar, samlingsløs gellankapsel og en proces til fremstilling heraf | |
| BRPI0707334B8 (pt) | formulação de cápsula de gelatina mole de um composto 15-ceto-prostaglandina e método para estabilização do um composto 15-cetoprostaglandina | |
| WO2012097429A8 (en) | Probiotic soft gel compositions | |
| BR112023020963A2 (pt) | Composição, método para encapsular microesferas liofilizadas, sistema e método para o controle da liberação de microesferas encapsuladas | |
| CO2022005947A2 (es) | Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas | |
| AR117242A1 (es) | Cápsulas basadas en almidón de alta amilosa y método para preparar las mismas | |
| AR122512A1 (es) | Cápsulas blandas de liberación retardada | |
| AR114434A1 (es) | Cápsulas de gelatina blanda entéricas | |
| AR090888A1 (es) | Vehiculos de liberacion de composiciones pesticidas | |
| AR062374A1 (es) | Metodo para prevenir la cristalizacion | |
| CL2021003286A1 (es) | Cápsula de tipo desintegración retardada y método para producir la misma. | |
| AR123805A1 (es) | Cápsulas blandas de liberación modificada | |
| AR087032A1 (es) | Composiciones de capsulas de gelatina y metodos para fabricarlas | |
| AR128560A1 (es) | Cápsula blanda de ácido valproico de liberación modificada | |
| AR130183A1 (es) | Cápsulas blandas entéricas recubiertas |